Literature DB >> 12764355

Complete remission induced by G-CSF in a patient with acute myeloid leukemia with t(8;21)(q22;q22).

Felicetto Ferrara1, Ettore Mariano Schiavone, Salvatore Palmieri, Giuseppina Mele, Barbara Pocali, Giulia Scalia, Paolo Morabito, Lucia Sebastio, Luigi Del Vecchio.   

Abstract

We describe a case of acute myeloid leukemia (AML) with t(8;21) in which complete remission (CR) was obtained with G-CSF given at 10 microg/kg in the absence of concomitant cytotoxic chemotherapy. CR was achieved following 2 weeks of therapy and confirmed by investigating minimal residual disease by four-color flow cytometry analysis. During treatment with G-CSF, maturing cells with cytoplasmic Auer Rods were observed in the peripheral blood, suggesting a differentiation effect. This case adds further evidence for a specific role of G-CSF in the treatment of AML with t(8;21), namely in patients who are not eligible for aggressive chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12764355     DOI: 10.1038/sj.thj.6200225

Source DB:  PubMed          Journal:  Hematol J        ISSN: 1466-4860


  2 in total

Review 1.  Granulocyte colony-stimulating factor and leukemogenesis.

Authors:  Lorena Lobo de Figueiredo; Rodrigo Siqueira de Abreu e Lima; Eduardo Magalhães Rego
Journal:  Mediators Inflamm       Date:  2004-06       Impact factor: 4.711

2.  The Vitamin E Analog Gamma-Tocotrienol (GT3) Suppresses Radiation-Induced Cytogenetic Damage.

Authors:  Rupak Pathak; Abdel Bachri; Sanchita P Ghosh; Igor Koturbash; Marjan Boerma; Regina K Binz; Jeffrey R Sawyer; Martin Hauer-Jensen
Journal:  Pharm Res       Date:  2016-05-23       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.